For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241114:nRSN2814Ma&default-theme=true
RNS Number : 2814M BATM Advanced Communications Ld 14 November 2024
LEI: 213800FLQUB9J289RU66
14 November 2024
BATM Advanced Communications Limited
("BATM" or "the Group")
Notice of Annual General Meeting and
Proposed Director Appointment
BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for
networking solutions and medical laboratory systems, gives notice that the
Annual General Meeting ("AGM" or the "Meeting") of the Group is to be held at
12.00pm Israel time (10.00am UK time) on 19 December 2024 at the Group's
registered office at 4 Ha'harash Street, Nave Ne'eman Industrial Area, P.O.B.
7318, 4524075 Hod Hasharon, Israel.
In order to enable shareholder engagement and participation for those unable
to physically attend the Meeting, shareholders will be able to access the
Meeting via videoconference.
Among the resolutions to be proposed to the AGM is a resolution appointing Dr.
Shmuel (Muli) Ben-Zvi as a Non-executive Director of the Group to take effect
from the conclusion of the Meeting.
Dr. Shmuel (Muli) Ben Zvi was elected Chairman of the board of Bank Leumi, the
largest banking corporation in Israel, in October 2023 for the final year of
his nine-year tenure as a director. At Bank Leumi, he was a member of the
board's audit, risk management, credit, technology and strategy committees.
Dr. Ben Zvi has extensive executive and board experience across multiple
industries, including currently being a director of Protalix Biotherapeutics
(NYSE American: PLX) and previously of Sol-Gel Technologies (NASDAQ: SLGL) and
VBL Therapeutics (NASDAQ: VBLT). From 2004 to 2014, he held a number of
managerial positions at Teva Pharmaceuticals (NASDAQ and TASE: TEVA),
including Vice President of Strategy and Vice President of Finance.
In accordance with Israeli Companies Law, the Group requires shareholder
approval to appoint a new Non-executive Director. The required disclosures
pursuant to UK Listing Rules 6.4.8 in relation to Dr. Ben Zvi will be made in
due course subject to his appointment.
Further information on the resolutions, notes and details on how to attend the
AGM via videoconference can be found in the Notice of AGM that, along with
forms of proxy and direction, has today been made available on BATM's website
at: www.batm.com
(https://url.avanan.click/v2/___http:/www.batm.com/___.YXAxZTpzaG9yZWNhcDphOm86YzRlYzc1YjU1NTVjMmE0ZTU3MGQwOGM0ZWNjMjRhZWQ6NjoxNDk3OmRhMDIzMDNjNDU5ZmQ4NjYwOTc1YTU1YmU1YzQ0NzUxMzE5OTZlMGJlYjk5MDM0YWJmYWIzZTU4ZTJiYzkzZjU6cDpGOk4)
.
Enquiries
BATM Advanced Communications
Moti Nagar, Chief Executive Officer +972 9866 2525
Ran Noy, Chief Financial Officer
Shore Capital
Mark Percy, Anita Ghanekar, James Thomas (Corporate Advisory) +44 20 7408 4050
Gracechurch Group
Harry Chathli, Claire Norbury +44 20 4582 3500
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NOABZLFFZFLZFBB